Jonathan M Oyler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jonathan M Oyler has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Edward J Cone
ConeChem Research, LLC, 441 Fairtree Dr., Severna Park, MD 21146
1 shared publicationEric T Moolchan
Chemistry and Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, 5500 Nathan Shock Dr., Baltimore, MD 21224
1 shared publicationMarilyn A Huestis
Chemistry and Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, 5500 Nathan Shock Dr., Baltimore, MD 21224
1 shared publicationRobert E Joseph
Amgen Inc., One Amgen Center Dr., Thousand Oaks, CA 91320
1 shared publication
Latest Publications
- Open Access
- 1 October 2002
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 48 (10) , 1703-1714
Duration of Detectable Methamphetamine and Amphetamine Excretion in Urine after Controlled Oral Administration of Methamphetamine to Humans
Background: Confirmation of a workplace drug test requires urinary methamphetamine (MAMP) and amphetamine (AMP) concentrations ≥500 and 200 μg/L, respectively, but cutoffs at half those values (250/100 μg/L) have been proposed. We determined the urinary excretion of MAMP after oral ingestion and examined the effect of using lower cutoffs on detection of exposure. Methods: Volunteers (n = 8) ingested four 10-mg doses of MAMP · HCl daily over 7 days, and five of them ingested four 20-mg doses 4 weeks later. After ingestion, the volunteers collected all urine specimens for 2 weeks. After solid-phase extraction, MAMP and AMP were measured by gas chromatography–positive chemical ionization mass spectrometry with dual silyl derivatization. Results: MAMP and AMP were generally detected in the first or second void (0.7–11.3 h) collected after drug administration, with concentrations of 82–1827 and 12–180 μg/L, respectively. Peak MAMP concentrations (1871–6004 μg/L) after single doses occurred within 1.5–60 h. MAMP ≥500 μg/L was first detected in the first or second void (1–11 h) at 524-1871 μg/L. Lowering the MAMP cutoff to 250 μg/L changed the initial detection time little. AMP ≥200 μg/L was first detected in the 2nd–13th (7–20 h) post-administration voids. At a cutoff of 100 μg/L, AMP was first confirmed in the second to eighth void (4–13 h). Reducing the cutoff to 250/100 μg/L extended terminal MAMP detection by up to 24 h, increased total detection time by up to 34 h, and increased the total number of positive specimens by 48%. Conclusions: At the lower cutoff, initial detection times are earlier, detection windows are longer, and confirmation rates are increased. Elimination of the AMP requirement would increase detection rates and allow earlier detection.
- 1 October 2002
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 48 (10) , 1703-1714
Open AccessDuration of Detectable Methamphetamine and Amphetamine Excretion in Urine after Controlled Oral Administration of Methamphetamine to Humans
Background: Confirmation of a workplace drug test requires urinary methamphetamine (MAMP) and amphetamine (AMP) concentrations ≥500 and 200 μg/L, respectively, but cutoffs at half those values (250/100 μg/L) have been proposed. We determined the urinary excretion of MAMP after oral ingestion and examined the effect of using lower cutoffs on detection of exposure. Methods: Volunteers (n = 8) ingested four 10-mg doses of MAMP · HCl daily over 7 days, and five of them ingested four 20-mg doses 4 weeks later. After ingestion, the volunteers collected all urine specimens for 2 weeks. After solid-phase extraction, MAMP and AMP were measured by gas chromatography–positive chemical ionization mass spectrometry with dual silyl derivatization. Results: MAMP and AMP were generally detected in the first or second void (0.7–11.3 h) collected after drug administration, with concentrations of 82–1827 and 12–180 μg/L, respectively. Peak MAMP concentrations (1871–6004 μg/L) after single doses occurred within 1.5–60 h. MAMP ≥500 μg/L was first detected in the first or second void (1–11 h) at 524-1871 μg/L. Lowering the MAMP cutoff to 250 μg/L changed the initial detection time little. AMP ≥200 μg/L was first detected in the 2nd–13th (7–20 h) post-administration voids. At a cutoff of 100 μg/L, AMP was first confirmed in the second to eighth void (4–13 h). Reducing the cutoff to 250/100 μg/L extended terminal MAMP detection by up to 24 h, increased total detection time by up to 34 h, and increased the total number of positive specimens by 48%. Conclusions: At the lower cutoff, initial detection times are earlier, detection windows are longer, and confirmation rates are increased. Elimination of the AMP requirement would increase detection rates and allow earlier detection.